Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability.
Role of intestinal microbiota in the development of multiple sclerosis.
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Phosphodiesterases in neurodegenerative disorders.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Innovating openly: researchers and patients turn to crowdsourcing to collaborate on clinical trials, drug discovery, and more.
Glial progenitor cell-based treatment and modeling of neurological disease.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
Biosynthetic Assembly of the Bacteroides fragilis Capsular Polysaccharide A Precursor Bactoprenyl Diphosphate-Linked Acetamido-4-amino-6-deoxygalactopyranose.
Implications of water channel proteins in selected neurological disorders: Epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies.
So many progenitors, so little myelin.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
Platelets and autoimmunity.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Platelets and neurovascular inflammation.

Pages